VCF, Vaginal Contraceptive Gel
CGMP deviations: out of specifications for assay
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Defective Delivery System: canister unit exhibiting propellant leakage or loss, rendering the product and canister unusable
Cause type: Packaging defect
Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.
VCF Vaginal Contraceptive Foam, a) can, 13 applications per can, Net wt. 0.6 oz (17g). NDC 52925-312-14, b) case pack with 36 cans in a nested container. Net wt 0.6 oz (17g) per can. NDC 52925-312-06, Distributed By: Apothecus Pharmaceutical Corp. Oyster Bay, NY 11771.
Compare with the code on your package — it is the most precise check available.
Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
CGMP deviations: out of specifications for assay
cGMP Diviations
Defective delivery system; product is not foaming or is coming out as liquid.
Defective delivery system; product is not foaming or is coming out as liquid.
Defective Delivery System: complaints for difficulty in pushing the plunger of the applicator.
Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.